Where there is Medical Research, there is Viable Healthcare

The Importance of Clinical Investigation and DiscoverySixty-five years ago Conrad Jobst applied his expertise and personal experience to the development of custom-made gradient compression garments and founded JOBST. The product lines expanded and the superior designs soon became synonymous with high quality and efficacy.

By: BSN Medical, Inc.

Clinical research is enormously important in that it has the ability to change individual patient’s lives for the better. It is with this research, and through discovery, that we create the future of healthcare. Sixty-five years ago, Conrad Jobst, the late mechanical engineer and inventor who suffered from vascular disease, applied his personal expertise and experience to research and development, creating custom-made gradient compression garments. In time, this discovery resulted in enhanced quality-of-life and improved health outcomes for countless people suffering from venous insufficiency or lymphatic disease.

Both research and education are integral to sustainable healthcare. Twenty years ago BSN, in association with the American Venous Forum (AVF), initiated the BSN-JOBST Research Grant for residents and fellows in vascular training, and physicians who completed training within the previous five years. In January 2015, BSN medical announced it was increasing the amount of its BSN-JOBST Research Grant in Venous and Lymphatic Diseases from a $50,000 annual grant to $100,000.

“The BSN Research Grant is designed to facilitate critical, new research to advance the understanding and treatment of venous disease, which might otherwise never be performed,” says Linda LaMagna, senior vice president of Wound Care Vascular for BSN.

“Data collected over the past two decades by grant recipients has contributed significantly to new therapy solutions and clinical advances, including compression therapy for the management of venous disease complications,” continues LaMagna. “Yet, in order to continue to expand knowledge, increase awareness and improve patient care, more research must be performed to provide consistent insight into future therapies.”

The 2015 Grant recipient is Andrew S. Kimball, M.D., resident surgeon at the University of Michigan Hospitals and Health Centers, in Ann Arbor. Dr. Kimball, who was presented the BSN-JOBST Research Grant at the AVF’s 27th Annual Meeting this past March, is investigating the mechanisms of venous thrombus resolution under the guidance and mentorship of Peter Henke, M.D., past president of the AVF.

“Since the start of medical school, I have always had a keen interest in the immune system,” says Dr. Kimball.

“Almost every disease process known to mankind is due to, relates to, or is affected by the immune system, and deep venous thrombosis (DVT) is no exception to this rule. Together with my mentors, Dr. Peter Henke and Dr. Katherine Gallagher, it is our goal to uncover the immunological basis of DVT resolution and utilize this information to help elucidate novel targets for the early diagnosis, prognosis, and treatment of venous thrombosis.”

According to AVF Foundation’s past President, Peter Pappas, M.D., a record number of proposals from promising young investigators were received this year. “As the very first recipient of the BSN-JOBST Research Grant, I am gratified to have witnessed numerous investigators who, over the past 20 years, have benefited from this opportunity and performed important research, further advancing the understanding and treatment of vein disease throughout the United States,” he says.

Research leads to the discovery of effective treatment and management options depending on the condition of venous disease states. Simultaneously, educational campaigns and published data help increase awareness of venous disease amongst patients and physicians, and the importance of compression therapy in the management and acceleration of venous wound healing.

BSN provides preventative and therapeutic solutions that range from compression therapy to wound management products that address all aspects of vein disease and individualized patient needs. It is BSN’s collaboration with clinical researchers – vascular residents, fellows, surgeons and other vascular professionals – that has resulted in markedly improved patient outcomes and lasting health. For BSN, philanthropy funding to help support vital research in the field of venous diseases to improve the quality of venous care in America is one of its most important contributions.

[return to issue]